G6PD deficiency among malaria-infected national groups at the western part of Myanmar with implications for primaquine use in malaria elimination
Abstract Background Glucose 6-phosphate dehydrogenase deficiency (G6PDd) plays a central role in readiness assessment for malaria elimination in Myanmar by 2030 that includes primaquine (PQ) use. The risk of hemolysis in G6PDd individuals hampers the widespread use of primaquine safely in malaria-in...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-06-01
|
Series: | Tropical Medicine and Health |
Online Access: | https://doi.org/10.1186/s41182-021-00339-7 |